NTLA - CIK 0001652130
Intellia Therapeutics, Inc. has filed 687 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (287 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-01-07 | 2025-01-03 |
| Insider trade | 4 | 2025-01-07 | 2025-01-03 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-01 |
| Insider trade | 4 | 2025-01-03 | 2025-01-01 |
| Insider trade | 4 | 2025-01-03 | 2025-01-01 |
| Major company event | 8-K | 2024-11-18 | 2024-11-16 |
| Quarterly report | 10-Q | 2024-11-07 | 2024-09-30 |
| Major company event | 8-K | 2024-11-07 | 2024-11-07 |
| Major company event | 8-K | 2024-10-25 | 2024-10-24 |
| Insider trade | 4 | 2024-10-04 | 2024-10-02 |
| Quarterly report | 10-Q | 2024-08-08 | 2024-06-30 |
| Major company event | 8-K | 2024-08-08 | 2024-08-08 |
| Insider trade | 4 | 2024-07-24 | 2024-07-22 |
| New insider ownership | 3 | 2024-07-24 | 2024-07-22 |
| Employee stock plan | S-8 | 2024-07-18 | - |
| Insider trade | 4 | 2024-07-03 | 2024-07-01 |
| Insider trade | 4 | 2024-07-03 | 2024-07-01 |
| Major company event | 8-K | 2024-06-26 | 2024-06-21 |
| Insider trade | 4 | 2024-06-20 | 2024-06-17 |
| New insider ownership | 3 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Major company event | 8-K | 2024-06-14 | 2024-06-12 |
| Insider trade | 4 | 2024-06-14 | 2024-06-12 |
| Insider trade | 4 | 2024-06-14 | 2024-06-12 |
| Insider trade | 4 | 2024-06-14 | 2024-06-12 |
| Insider trade | 4 | 2024-06-14 | 2024-06-12 |
| Insider trade | 4 | 2024-06-14 | 2024-06-12 |
| Insider trade | 4 | 2024-06-14 | 2024-06-12 |
| Major company event | 8-K | 2024-06-13 | 2024-06-12 |
| Quarterly report | 10-Q | 2024-05-09 | 2024-03-31 |
| Major company event | 8-K | 2024-05-09 | 2024-05-09 |
| Annual report to shareholders | ARS | 2024-04-29 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-29 | - |
| Proxy statement | DEF 14A | 2024-04-29 | 2024-06-12 |
| New insider ownership | 3 | 2024-04-22 | 2024-04-10 |
| PRE 14A | - | 2024-04-16 | 2024-06-12 |
| Major company event | 8-K | 2024-04-15 | 2024-04-10 |
| Major company event | 8-K | 2024-03-22 | 2024-03-19 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Prospectus supplement | 424B5 | 2024-02-26 | - |
| Prospectus supplement | 424B5 | 2024-02-23 | - |
| Major company event | 8-K | 2024-02-23 | 2024-02-23 |
| Employee stock plan | S-8 | 2024-02-22 | - |